Belgian Pharma Stock News

As global markets navigate a period of heightened economic activity and mixed signals from earnings reports, investors are keenly observing the performance of major indices, which have seen fluctuations amid busy data weeks. With value stocks showing resilience compared to their growth counterparts, this environment presents an opportunity to identify stocks that may be trading below their intrinsic worth. In such a climate, finding undervalued stocks requires a focus on strong fundamentals...

In a week marked by busy earnings reports and economic data releases, global markets saw major indices like the Nasdaq Composite and S&P MidCap 400 hit record highs before retreating, while small-cap stocks showed resilience compared to their larger counterparts. Amidst this backdrop of cautious optimism and mixed signals from the labor market, investors are keenly watching high-growth tech stocks that demonstrate strong fundamentals and potential for innovation-driven expansion.

With a price-to-sales (or "P/S") ratio of 18.7x argenx SE ( EBR:ARGX ) may be sending very bearish signals at the...

Melexis ( EBR:MELE ) Third Quarter 2024 Results Key Financial Results Revenue: €247.9m (flat on 3Q 2023). Net income...

While not a mind-blowing move, it is good to see that the Solvay SA ( EBR:SOLB ) share price has gained 18% in the last...

Key Insights Barco's estimated fair value is €14.51 based on 2 Stage Free Cash Flow to Equity Barco's €11.45 share...

Key Insights Kinepolis Group's significant private companies ownership suggests that the key decisions are influenced...

Key Insights Significant control over Umicore by individual investors implies that the general public has more power to...

Proximus ( EBR:PROX ) Third Quarter 2024 Results Key Financial Results Revenue: €1.75b (up 15% from 3Q 2023). Net...

Key Insights Significant control over Elia Group by private companies implies that the general public has more power to...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...

Hyloris Pharmaceuticals ( EBR:HYL ) First Half 2024 Results Key Financial Results Revenue: €4.64m (up 143% from 1H...

With a price-to-sales (or "P/S") ratio of 6.1x UCB SA ( EBR:UCB ) may be sending very bearish signals at the moment...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But investors can...

Key Insights Proximus' estimated fair value is €4.96 based on 2 Stage Free Cash Flow to Equity Proximus is estimated to...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But investors can...

Tessenderlo Group NV's ( EBR:TESB ) price-to-earnings (or "P/E") ratio of 17.7x might make it look like a sell right...

Key Insights VGP's significant private companies ownership suggests that the key decisions are influenced by...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...

Key Insights bpost/SA's significant sovereign wealth funds ownership suggests that the key decisions are influenced by...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...